PACCAR Inc. (NASDAQ:PCAR) shares moved up 1.57% in last trading session and ended the day at $46.53. PCAR Gross Margin is 18.80% and its has a return on assets of 7.90%. PACCAR Inc. (NASDAQ:PCAR) quarterly performance is -8.75%.
PACCAR Inc. (NASDAQ:PCAR) said that, it is expected to report its 77th consecutive year of net profit for 2015 once the final figures are in, and fundamentals remain strong. The company has paid a regular dividend for more than 70 years and has no debts on the manufacturing side of business, only on the finance and leasing division.
JPMorgan Chase & Co. (NYSE:JPM) caters to the Financial space. It has a net profit margin of 44.00% and weekly performance is -2.15%. On the last day of trading company shares ended up at $56.95. JPMorgan Chase & Co. (NYSE:JPM) distance from 50-day simple moving average (SMA50) is -11.29%.
JPMorgan Chase & Co. (NYSE:JPM) announced that its CEO James Dimon will be paid $27 million for 2015. Compared to the preceding year, his compensation package has increased by 35%.
On 22 January, New Residential Investment Corp. (NYSE:NRZ) shares moved up 4.95% and was closed at $10.60. NRZ EPS growth in last 5 year was 48.44%. New Residential Investment Corp. (NYSE:NRZ) year to date (YTD) performance is -12.83%.
JMP Securities started coverage on shares of New Residential Investment Corp (NYSE:NRZ) in a research report published on Wednesday, The Fly reports. The brokerage issued an outperform rating and a $15.00 price objective on the real estate investment trust’s stock.
Aimmune Therapeutics, Inc. (NASDAQ:AIMT) shares moved up 14.82% in last trading session and ended the day at $15.42. AIMT has a return on assets of -35.00%. Aimmune Therapeutics, Inc. (NASDAQ:AIMT) quarterly performance is 2.19%.
On 11 January, Aimmune Therapeutics, Inc. (NASDAQ:AIMT) announced that it has enrolled the first patient in the pivotal Phase 3 PALISADE trial of its lead product candidate, AR101 for the treatment of peanut allergy. More than five million people in the United States and Europe have peanut allergy, an increasingly prevalent, potentially life-threatening, chronic condition for which there are no approved treatments.
QUALCOMM, Inc. (NASDAQ:QCOM) caters to the Technology space. It has a net profit margin of 20.80% and weekly performance is 0.71%. On the last day of trading company shares ended up at $48.07. QUALCOMM, Inc. (NASDAQ:QCOM) distance from 50-day simple moving average (SMA50) is -8.28%.
GlaxoSmithKline and QUALCOMM, Inc. (NASDAQ:QCOM) are in talks to set up a joint venture potentially worth up to $1bn to develop medical technology — the latest example of convergence between the healthcare and technology industries.
Leave a Reply